2024-11-04T15:59:45-07:00 2023-12-31 262176601 EASY OFFICE DBA JITASA 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 990 2023-07-01 932385426 BLUEPRINT BIOSECURITY BLUE 2029293933 1775 I STREET NW SUITE 1150 WASHINGTON DC 20006 JACOB SWETT PRESIDENT AND EXECUTIVE DIRECTOR 2029293933 2024-11-04 1 1 JEREMY CORK P01544850 2082874777 2024-11-04 2023 2024-10-15 13:58:12Z X JACOB SWETT 1775 I STREET NW SUITE 1150 WASHINGTON DC 20006 2583112 0 X WWW.BLUEPRINTBIOSECURITY.ORG X 2023 DC THE MISSION OF THE ORGANIZATION IS TO ACHIEVE BREAKTHROUGHS IN HUMANITY`S CAPABILITY TO PREVENT, MILITIGATE, AND SUPPRESS PANDEMICS. 4 3 4 4 0 0 0 2583000 0 0 0 110 0 2 0 2583112 0 0 0 0 0 389964 0 0 11836 0 175564 0 565528 0 2017584 0 2036040 0 18456 0 2017584 BLUEPRINT BIOSECURITY IS A NONPROFIT DEDICATED TO ENDING PANDEMICS. WE DO THIS BY FIRST CREATING DETAILED AND PRACTICAL PLANS FOR ACCELERATING THE DEVELOPMENT OF PANDEMIC PREVENTION TECHNOLOGIES AND POLICIES. WE THEN WORK WITH PARTNERS ACROSS GOVERNMENT, ACADEMIA, AND INDUSTRY TO PUT THOSE PLANS INTO ACTION. 0 0 209576 0 0 GENERAL PROGRAM - BLUEPRINT BIOSECURITY'S GENERAL PROGRAM BROADLY SUPPORTS OUR MISSION TO MITIGATE THE RISK OF PANDEMICS THROUGH DEVELOPING ACTIONABLE PLANS, STAKEHOLDER ENGAGEMENT, AND EFFECTIVE EXECUTION OF OUR INITIATIVES. WE SUPPORT AND CONVENE CONFERENCES, WORKSHOPS, AND OTHER PUBLIC EVENTS TO SHARE OUR RESEARCH AND STRATEGIES FOR PANDEMIC PREVENTION. WE ENGAGE WITH AND EDUCATE KEY STAKEHOLDERS, INCLUDING GOVERNMENTS, RESEARCHERS, THINK TANKS, AND PHILANTHROPISTS, TO BUILD STRONG NETWORKS ESSENTIAL FOR EFFECTIVE PANDEMIC PREVENTION. OUR FOCUS IS ON DEVELOPING COLLABORATIVE RELATIONSHIPS THAT FACILITATE THE IMPLEMENTATION OF COMPREHENSIVE BIOSECURITY MEASURES. OUR MULTIDISCIPLINARY TEAMS WORK COLLABORATIVELY TO EXECUTE OUR STRATEGIC INITIATIVES, WHICH INCLUDE CONDUCTING RESEARCH, DEVELOPING ACTIONABLE PLANS, FUNDING STUDIES, AND IMPLEMENTING PILOT PROGRAMS. THROUGH THESE ACTIVITIES, BLUEPRINT BIOSECURITY AIMS TO CREATE A RESILIENT FRAMEWORK CAPABLE OF PREVENTING AND MITIGATING THE IMPACTS OF FUTURE PANDEMICS, ULTIMATELY LEADING TO A SAFER AND MORE PREPARED WORLD. BY DECEMBER 2023, WE CONDUCTED ABOUT 50 EXPERT INTERVIEWS ACROSS A WIDE SPECTRUM OF THE BIOSECURITY FIELD. THIS RESULTED IN A DATABASE OF OVER 200 IDEAS FOR INTERVENTIONS CATEGORIZED ACROSS EIGHT CATEGORIES. BASED ON OUR REVIEW OF THE FINDINGS AND ASSESSMENT OF OUR ORGANIZATION'S STRENGTHS AND WHERE OTHER ORGANIZATIONS ARE FOCUSING, WE DECIDED TO INITIALLY PRIORITIZE RESEARCH ON PATHOGEN TRANSMISSION SUPPRESSION, SPECIFICALLY THE SET OF INTERVENTIONS THAT ARE EFFECTIVE AGAINST A BROAD RANGE OF PATHOGENS AND SHOW PROMISE FOR MAKING IT MUCH MORE DIFFICULT FOR HIGHLY INFECTIOUS RESPIRATORY PATHOGENS TO SPREAD. THIS WORK HAS TWO PRIMARY SUB-COMPONENTS: BUILT ENVIRONMENT TRANSMISSION SUPPRESSION AND THE NEXT GENERATION OF PERSONAL PROTECTIVE EQUIPMENT. 111671 0 0 FAR UVC - OUR MAIN FAR-UVC PROJECT IS ASSESSING FAR-UVC AS A TOOL FOR PANDEMIC PREVENTION AND WRITING A ROADMAP FOR ACCELERATING ITS RESEARCH, DEVELOPMENT, AND DEPLOYMENT. ADDITIONALLY, WE HAVE CONDUCTED MODELING OF THE EFFICACY OF FAR-UVC, SUPPORTED RESEARCH ON EYE SAFETY, AND SUPPORTED CONFERENCES AND WORKSHOPS ON FAR-UVC. OUR UPCOMING FAR-UVC ROADMAP, WHICH WE CALL A 'BLUEPRINT,' TACKLES THE PROMISE AND COMPLEXITIES OF USING FAR-UVC TO CLEAN THE AIR OF INFECTIOUS PATHOGENS. IT INCLUDES EXTENSIVE REVIEWS AND ANALYSES OF: DISINFECTION EFFICACY AND TRANSMISSION SUPPRESSION, SAFETY AND OTHER POSSIBLE UNINTENDED CONSEQUENCES, REGULATIONS & STANDARDS RELEVANT TO THE USE OF FAR-UVC, CURRENT AND FUTURE LAMP TECHNOLOGY, AND A COST-BENEFIT ANALYSIS. WE GROUND THIS ANALYSIS WITH COMPREHENSIVE LITERATURE REVIEWS, INTERVIEWS WITH EXPERTS, AND ORIGINAL MODELING. OUR ROADMAP WILL OUTLINE ESSENTIAL STEPS FOR THE DEVELOPMENT OF FAR-UVC AS A TOOL FOR SAFER INDOOR SPACES AND PANDEMIC PREVENTION. THE ULTIMATE GOAL OF A BLUEPRINT IS TO ELEVATE OUR COLLECTIVE AMBITIONS AND SHOW HOW EVERYONE- FROM RESEARCHERS, ENTREPRENEURS, REGULATORS, LEGISLATORS, GOVERNMENTS, PHILANTHROPISTS, AND MEMBERS OF CIVIL SOCIETY- CAN CONTRIBUTE TO PREVENTING THE NEXT PANDEMIC. TO SUPPORT RESEARCH ON EYE SAFETY, WE LAUNCHED A REQUEST FOR PROPOSALS (RFP) TO IDENTIFY AND FUND GRANT OPPORTUNITIES FOR FURTHER UV-C EYE SAFETY STUDIES. CURRENT RESEARCH, PRIMARILY FOCUSED ON WAVELENGTHS AT 222 NM, SHOWS FAR-UVC IS MOSTLY ABSORBED BY THE STRATUM CORNEUM IN THE CASE OF SKIN, AND IN THE CASE OF EYES, THE SUPERFICIAL EPITHELIAL CELLS OF THE CORNEA AND POTENTIALLY THE TEAR FILM. THROUGH OUR GRANTS, WE SEEK TO UNDERSTAND WHAT (IF ANY) LEVEL OF EYE EXPOSURE TO FAR-UVC LEADS TO SUBJECTIVE OCULAR DISCOMFORT AND THE POTENTIAL METHODS OF MEASURING AND UNDERSTANDING OCULAR IRRITATION. ANY IDENTIFIED IRRITATION BIOMARKERS CAN THEN BE USED TO 1) STUDY OCULAR IRRITATION AND 2) DETERMINE THE HIGHEST FAR-UVC DOSE FOR PATHOGEN STERILIZATION THAT DOES NOT INDUCE OCULAR IRRITATION. 101921 0 0 BUILT ENVIROMENT TRANSMISSION SUPPRESSION - OUR PHYSICAL ENVIRONMENTS - FROM AIRPORTS TO CHILDCARE CENTERS, FACTORIES, AND SCHOOLS - PLAY A MAJOR ROLE IN THE SPREAD OF PATHOGENS. BUT THERE ARE MANY FUNDAMENTAL OPEN QUESTIONS ABOUT INDOOR TRANSMISSION THAT LEAVE US VULNERABLE TO NEW PANDEMICS: IN WHICH SPECIFIC BUILT ENVIRONMENTS DO HIGHLY CONTAGIOUS DISEASES CURRENTLY SPREAD MOST EASILY? WHICH NASCENT TECHNOLOGIES SHOW THE MOST PROMISE FOR REDUCING INDOOR PATHOGEN TRANSMISSION? WHAT UPGRADES ARE MOST FEASIBLE IN THE PLACES WHERE THEY'D MAKE THE BIGGEST DIFFERENCE? OUR BUILT ENVIRONMENT TRANSMISSION SUPPRESSION PROJECT EXPLORES THESE QUESTIONS IN DEPTH. WE'RE CURRENTLY EVALUATING A WIDE RANGE OF TECHNOLOGIES AND INTERVENTIONS THAT HAVE THE POTENTIAL TO SIGNIFICANTLY REDUCE INDOOR PATHOGEN TRANSMISSION AND DEVELOPING MODELS TO UNDERSTAND WHICH SPECIFIC ENVIRONMENTS BEAR THE GREATEST BURDEN OF TRANSMISSION. ONCE THESE RESULTS ARE IN, WE'LL PUBLISH OUR INVESTIGATIONS AND WRITE A STRATEGIC ROADMAP FOR HOW INTERESTED STAKEHOLDERS CAN HELP ACCELERATE THE MOST PROMISING SOLUTIONS. THIS INVESTIGATION WILL SET US UP FOR A LARGER PROJECT THAT RIGOROUSLY TESTS THESE INITIAL FINDINGS, GOES DEEPER INTO THE MOST PROMISING INTERVENTIONS AND COMBINATIONS OF INTERVENTIONS, INVESTIGATES HOW FEASIBLE IMPLEMENTATION WOULD BE AND THE ANTICIPATED CHALLENGES, AND EVALUATES THE WORK OF OTHER STAKEHOLDERS IN THE SPACE. ULTIMATELY, THE GOAL IS TO CREATE A DETAILED BLUEPRINT, A ROADMAP THAT LAYS OUT THE PATH FOR BRINGING ABOUT THE DESIRED SOLUTION, FOR SUPPRESSING THE TRANSMISSION OF PATHOGENS IN THE BUILT ENVIRONMENT. 899 0 0 OTHER PROGRAMS 899 0 0 424067 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 1 4 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 4 3 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AK DC NH RI X X EASY OFFICE DBA JITASA 2082874777 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 JACOB SWETT PRESIDENT AND EXECUTIVE DIRECTOR 1 X 83333 0 0 SAM BELL SECRETARY AND TREASURER UNTIL DECEMBER 0.5 X X 0 0 0 JASPREET PANNU SECRETARY AND TREASURER SINCE DECEMBER 0.5 X X 0 0 0 CHARLIE PETTY BOARD MEMBER 0.5 X 0 0 0 ANDREW SYNDER BEATTIE BOARD MEMBER 0.5 X 0 0 0 83333 0 0 0 0 0 0 0 0 0 0 0 0 2583000 0 2583000 0 110 0 0 110 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 2 2583112 2 0 110 X 83334 62500 19167 1667 0 227181 202130 16507 8544 5256 0 5256 0 26632 4136 22496 0 47561 39253 6683 1625 7456 0 7456 0 12800 0 12800 0 109979 79161 30818 0 2407 1740 667 0 755 0 755 0 661 0 661 0 30908 30908 0 0 1754 1754 0 0 1221 0 1221 0 DUES & SUBSCRIPTIONS 7036 2485 4551 0 MISCELLANEOUS EXPENSES 587 0 587 0 565528 424067 129625 11836 50539 1983095 2406 0 2036040 18456 0 18456 X 0 1702373 0 315211 0 2017584 0 2036040 2017584 0 0 0 0 0 X 0 0 0 X 2583000 2583000 0 0 0 0 2583000 2583000 2131338 451662 110 110 2 2 2583112 X Schedule A, Part II, Line 10 MISCELLANEOUS REVENUE RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Europe (including Iceland and Greenland) 0 0 Fundraising 0 0 0 0 0 0 0 0 0 0 Schedule F, Part I, Line 3 THERE ARE NO EXPENSES FOR FOREIGN DONATIONS. THE ASSOCIATED COSTS ARE REPRESENTED BY THE PERCENTAGE OF JACOB SWETT`S SALARY, A U.S. EMPLOYEE, ALLOCATED TO FUNDRAISING, WHICH IS RECORDED AS ZERO COSTS FOR FOREIGN DONATIONS. Form 990, Part VI, Section A, Line 4 1- BOARD MEMBER CHANGE - SAM BELL RESIGNED IN DEC, HIS SEAT AND OFFICER ROLES WERE REPLACED BY JASPREET PANNU. 2 - WE AMENDED OUR BYLAWS, NEW COPY AND SIGNED UNANIMOUS CONSENT ATTACHED. Form 990, Part VI, Section B, Line 11b CHIEF OPERATING OFFICER WILL REVIEW FORM 990, AFTER WHICH IT WILL BE DRAFT DISTRIBUTED TO BOARD MEMBERS WITH DETAILED DESCRIPTIONS EXPLAINING FORM 990, OPPORTUNITIES FOR QUESTIONS AND CONSULTATIONS WILL BE PROVIDED TO ALL BOARD MEMBERS BEFORE SUBMISSION. Form 990, Part VI, Section B, Line 12c CONTINUED DISCUSSION ITEM, FLAGGING AND REVIEWING POTENTIALS COIS, TRAINING PROVIDED. Form 990, Part VI, Section B, Line 15 THE PROCESS TO ESTABLISH COMPENSATION INVOLVED RESEARCHING VARIOUS SOURCES, INCLUDING PUBLIC 990 TAX RETURNS, DATA FROM THINK TANKS AND FOUNDATIONS, THIRD-PARTY BENCHMARKING STUDIES, AND SALARY RANGES FROM PUBLICLY AVAILABLE JOB ADS AND PLATFORMS SUCH AS GLASSDOOR, ALL WHILE CONSIDERING THE FACTORS OF LOCATION AND ORGANIZATION SIZE. BASED ON THIS RESEARCH, THE BOARD MADE THE FINAL DECISION TO SET COMPENSATION FOR SPECIFIC ROLES, ALIGNING THEIR DECISION WITH THE COLLECTED INDUSTRY DATA AND ENSURING CONSISTENCY WITH THE ORGANIZATION'S COMPENSATION STRUCTURE. Form 990, Part VI, Section C, Line 19 FINANCIAL AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REASONABLE REQUEST. FORM 990 CAN BE ACCESSED VIA IRS.GOV AND GUIDESTAR.ORG WEBSITES. Form 990, Part IX, Line 11g OTHER FEES